QuidelOrtho (NASDAQ:QDEL) & United Health Products (OTCMKTS:UEEC) Head to Head Comparison

QuidelOrtho (NASDAQ:QDEL – Get Free Report) and United Health Products (OTCMKTS:UEEC – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, risk, valuation and profitability.

Earnings and Valuation

This table compares QuidelOrtho and United Health Products”s gross revenue, earnings per share and valuation.

United Health Products has lower revenue, but higher earnings than QuidelOrtho. United Health Products is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares QuidelOrtho and United Health Products’ net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent recommendations and price targets for QuidelOrtho and United Health Products, as provided by MarketBeat.

QuidelOrtho currently has a consensus price target of $31.50, suggesting a potential upside of 113.13%. Given QuidelOrtho’s stronger consensus rating and higher probable upside, equities research analysts plainly believe QuidelOrtho is more favorable than United Health Products.

Insider and Institutional Ownership

99.0% of QuidelOrtho shares are owned by institutional investors. Comparatively, 0.1% of United Health Products shares are owned by institutional investors. 0.8% of QuidelOrtho shares are owned by company insiders. Comparatively, 1.5% of United Health Products shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility & Risk

QuidelOrtho has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Comparatively, United Health Products has a beta of -0.89, indicating that its share price is 189% less volatile than the S&P 500.

Summary

QuidelOrtho beats United Health Products on 9 of the 13 factors compared between the two stocks.

About QuidelOrtho

(Get Free Report)

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

About United Health Products

(Get Free Report)

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.